A positive result from high throughput screening. Compounds resulting in hits are collected for further testing in which further potency or effectiveness may be determined. If hits demonstrate further potency, they become lead compounds.
Glossary
Hit
02.27.12
-
Drug Development
Solving the Pharma Talent Crunch
Addressing talent shortages in today's pharmaceutical sectorJim Sykes, Managing Director, Pharmaceutical & Life Sciences, Alexander Mann Solutions
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Merck, Stelis Open First Joint Process Scale-Up Lab in Bengaluru
Combines Stelis' bioprocess development capabilities with Merck's bioprocessing equipment
-
Breaking News | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
Dow Offers New Technology to Solve Pharma Challenges
Company’s silicone chemistries target cost control, product differentiation and solubility challenges
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Industry News | Preclinical Outsourcing
Catalent Biologics Collaborates with Therachon
Will advance clinical development of innovative protein therapy for achondroplasia
